Cardiovascular psychiatry and neurology最新文献

筛选
英文 中文
P2X(7) Receptors in Neurological and Cardiovascular Disorders. P2X(7)受体在神经和心血管疾病中的作用。
Cardiovascular psychiatry and neurology Pub Date : 2009-01-01 Epub Date: 2009-06-24 DOI: 10.1155/2009/861324
Stephen D Skaper, Patrizia Debetto, Pietro Giusti
{"title":"P2X(7) Receptors in Neurological and Cardiovascular Disorders.","authors":"Stephen D Skaper,&nbsp;Patrizia Debetto,&nbsp;Pietro Giusti","doi":"10.1155/2009/861324","DOIUrl":"https://doi.org/10.1155/2009/861324","url":null,"abstract":"<p><p>P2X receptors are ATP-gated cation channels that mediate fast excitatory transmission in diverse regions of the brain and spinal cord. Several P2X receptor subtypes, including P2X(7), have the unusual property of changing their ion selectivity during prolonged exposure to ATP, which results in a channel pore permeable to molecules as large as 900 daltons. The P2X(7) receptor was originally described in cells of hematopoietic origin, and mediates the influx of Ca(2+) and Na(+) and Ca(2+) and Na(+) ions as well as the release of proinflammatory cytokines. P2X(7) receptors may affect neuronal cell death through their ability to regulate the processing and release of interleukin-1beta, a key mediator in neurodegeneration, chronic inflammation, and chronic pain. Activation of P2X(7), a key mediator in neurodegeneration, chronic inflammation, and chronic pain. Activation of P2X(7) receptors provides an inflammatory stimulus, and P2X(7) receptor-deficient mice have substantially attenuated inflammatory responses, including models of neuropathic and chronic inflammatory pain. Moreover, P2X(7) receptor activity, by regulating the release of proinflammatory cytokines, may be involved in the pathophysiology of depression. Apoptotic cell death occurs in a number of vascular diseases, including atherosclerosis, restenosis, and hypertension, and may be linked to the release of ATP from endothelial cells, P2X(7) receptor activation, proinflammatory cytokine production, and endothelial cell apoptosis. In this context, the P2X(7) receptor may be viewed as a gateway of communication between the nervous, immune, and cardiovascular systems.</p>","PeriodicalId":88441,"journal":{"name":"Cardiovascular psychiatry and neurology","volume":"2009 ","pages":"861324"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2009/861324","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28610219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
Omega-3 Polyunsaturated Fatty Acids (n-3 PUFAs) in Cardiovascular Diseases (CVDs) and Depression: The Missing Link? Omega-3多不饱和脂肪酸(n-3 PUFAs)与心血管疾病(cvd)和抑郁症:缺失的环节?
Cardiovascular psychiatry and neurology Pub Date : 2009-01-01 Epub Date: 2009-09-27 DOI: 10.1155/2009/725310
Jane Pei-Chen Chang, Yi-Ting Chen, Kuan-Pin Su
{"title":"Omega-3 Polyunsaturated Fatty Acids (n-3 PUFAs) in Cardiovascular Diseases (CVDs) and Depression: The Missing Link?","authors":"Jane Pei-Chen Chang,&nbsp;Yi-Ting Chen,&nbsp;Kuan-Pin Su","doi":"10.1155/2009/725310","DOIUrl":"https://doi.org/10.1155/2009/725310","url":null,"abstract":"<p><p>Background. Based on epidemiological data, clinical trials, and meta-analytic reviews, omega-3 polyunsaturated fatty acids (n-3 PUFAs) seem to be a biological link between depression and cardiovascular diseases (CVDs). Presentation. Involvement of n-3 PUFAs in depression and CVDs may be associated with a chronic, low-grade, inflammation. We hypothesize that n-3 PUFAs link depression and CVDs via \"PUFA-prostaglandin E2 (PGE2) cascade.\" Testing. To further support our hypothesis, case-control studies are needed to test the role of COX2 and PLA2 functions in depression and in CVDs. In addition, the effects of n-3 PUFAs on cardiovascular markers in depression and on depressive symptoms in CVDs should be investigated in clinical trials. Finally, the effects of manipulating COX2 and PLA2 functions on depression-like behaviors and cardiovascular functions could be explored in animal studies. Implications. n-3 PUFAs might be a promising treatment for both cardiovascular diseases and depression via its anti-inflammatory, cardioprotective, and neuroprotective effects.</p>","PeriodicalId":88441,"journal":{"name":"Cardiovascular psychiatry and neurology","volume":"2009 ","pages":"725310"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2009/725310","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28610281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 19
Interleukin-10: a key cytokine in depression? 白细胞介素-10:抑郁症的关键细胞因子?
Cardiovascular psychiatry and neurology Pub Date : 2009-01-01 Epub Date: 2009-08-16 DOI: 10.1155/2009/187894
Susana Roque, Margarida Correia-Neves, Ana Raquel Mesquita, Joana Almeida Palha, Nuno Sousa
{"title":"Interleukin-10: a key cytokine in depression?","authors":"Susana Roque,&nbsp;Margarida Correia-Neves,&nbsp;Ana Raquel Mesquita,&nbsp;Joana Almeida Palha,&nbsp;Nuno Sousa","doi":"10.1155/2009/187894","DOIUrl":"https://doi.org/10.1155/2009/187894","url":null,"abstract":"<p><p>An increasing body of evidence implicates proinflammatory cytokines in psychiatric disorders, namely, in depression. Of notice, recent studies showed that anti-inflammatory cytokines, such as IL-10, also modulate depressive-like behavior. In this article, we propose that the anti-inflammatory cytokine IL-10 is a putative link between two of the most widely reported phenomenon observed in depressed patients: the disruption of the hypothalamic-pituitary-adrenal axis and the imbalanced production of cytokines. If so, IL-10 might represent a novel target for antidepressant therapy.</p>","PeriodicalId":88441,"journal":{"name":"Cardiovascular psychiatry and neurology","volume":"2009 ","pages":"187894"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2009/187894","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28527103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 74
Do Neural Cells Communicate with Endothelial Cells via Secretory Exosomes and Microvesicles? 神经细胞是否通过分泌外泌体和微泡与内皮细胞沟通?
Cardiovascular psychiatry and neurology Pub Date : 2009-01-01 Epub Date: 2009-08-03 DOI: 10.1155/2009/383086
Neil R Smalheiser
{"title":"Do Neural Cells Communicate with Endothelial Cells via Secretory Exosomes and Microvesicles?","authors":"Neil R Smalheiser","doi":"10.1155/2009/383086","DOIUrl":"https://doi.org/10.1155/2009/383086","url":null,"abstract":"<p><p>Neurons, glial, cells, and brain tumor cells tissues release small vesicles (secretory exosomes and microvesicles), which may represent a novel mechanism by which neuronal activity could influence angiogenesis within the embryonic and mature brain. If CNS-derived vesicles can enter the bloodstream as well, they may communicate with endothelial cells in the peripheral circulation and with cells concerned with immune surveillance.</p>","PeriodicalId":88441,"journal":{"name":"Cardiovascular psychiatry and neurology","volume":"2009 ","pages":"383086"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2009/383086","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28609773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 33
The potential for xanthine oxidase inhibition in the prevention and treatment of cardiovascular and cerebrovascular disease. 黄嘌呤氧化酶抑制在心脑血管疾病防治中的潜力。
Cardiovascular psychiatry and neurology Pub Date : 2009-01-01 Epub Date: 2009-11-04 DOI: 10.1155/2009/282059
Peter Higgins, Jesse Dawson, Matthew Walters
{"title":"The potential for xanthine oxidase inhibition in the prevention and treatment of cardiovascular and cerebrovascular disease.","authors":"Peter Higgins,&nbsp;Jesse Dawson,&nbsp;Matthew Walters","doi":"10.1155/2009/282059","DOIUrl":"https://doi.org/10.1155/2009/282059","url":null,"abstract":"<p><p>There is a now a wealth of epidemiological, animal, and clinical data to suggest the benefits of uric acid reduction and hxanthine oxidase inhibition in prevention of vascular disease. This review discusses the available epidemiological, preclinical, and clinical data and considers arguments for and against a role for serum uric acid in common cardiovascular disorders. It concludes that large scale trials with clinical endpoints are justified to address this important question and to define whether use of drugs such as allopurinol should be a routine part of preventative strategies.</p>","PeriodicalId":88441,"journal":{"name":"Cardiovascular psychiatry and neurology","volume":"2009 ","pages":"282059"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2009/282059","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28609772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 46
Chromatin from peripheral blood mononuclear cells as biomarkers for epigenetic abnormalities in schizophrenia. 外周血单核细胞染色质作为精神分裂症表观遗传异常的生物标志物。
Cardiovascular psychiatry and neurology Pub Date : 2009-01-01 Epub Date: 2009-07-22 DOI: 10.1155/2009/409562
David P Gavin, Rajiv P Sharma
{"title":"Chromatin from peripheral blood mononuclear cells as biomarkers for epigenetic abnormalities in schizophrenia.","authors":"David P Gavin,&nbsp;Rajiv P Sharma","doi":"10.1155/2009/409562","DOIUrl":"https://doi.org/10.1155/2009/409562","url":null,"abstract":"<p><p>Background. Studies have implicated abnormalities in epigenetic gene regulation in schizophrenia. Presentation. We hypothesize that identifying abnormalities in chromatin structure and the epigenetic machinery in peripheral blood mononuclear cells (PBMC) from schizophrenia patients could (a) help characterize a subset of schizophrenia patients and (b) lead to targeted pharmacological interventions. Testing. Investigate the relationship between clinical symptoms, demographics, hormonal fluctuations, substance abuse, disease characteristics across the major mental illnesses, and epigenetic parameters in PBMC. In addition, examine the effects of individual antipsychotics, mood stabilizers, as well as experimental agents both as clinically prescribed as well as in cultured PBMC to understand the effects of these agents on chromatin. Implications. If PBMC could serve as a reliable model of overall epigenetic mechanisms then this could lead to a \"biomarker\" approach to revealing pathological chromatin state in schizophrenia. This approach may provide an informed method for selecting chromatin modifying agents for psychiatric disorders.</p>","PeriodicalId":88441,"journal":{"name":"Cardiovascular psychiatry and neurology","volume":"2009 ","pages":"409562"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2009/409562","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28609774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 24
Depression with panic episodes and coronary vasospasm. 抑郁症伴惊恐发作和冠状血管痉挛。
Cardiovascular psychiatry and neurology Pub Date : 2009-01-01 Epub Date: 2009-06-01 DOI: 10.1155/2009/453786
Mladen I Vidovich, Aneet Ahluwalia, Radmila Manev
{"title":"Depression with panic episodes and coronary vasospasm.","authors":"Mladen I Vidovich,&nbsp;Aneet Ahluwalia,&nbsp;Radmila Manev","doi":"10.1155/2009/453786","DOIUrl":"https://doi.org/10.1155/2009/453786","url":null,"abstract":"<p><p>Variant (Prinzmetal's) angina is an uncommon cause of precordial pain caused by coronary vasospasm and characterized by transient ST elevation and negative markers of myocardial necrosis. This is the case of a female patient with a prior history of depression and panic attacks who presented with recurrent symptoms including chest pain. A cardiac event monitor positively documented coronary vasospasm associated with anxiety-provoking chest pain, whereas the coronary arteries were angiographically normal. We noted that the frequency of angina attacks apparently increased during the period that coincided with the introduction of Bupropion SR for treatment of the patient's depression. Considering the possibility of bupropion-associated negative impact on coronary vasospasm, the antidepressant therapy was adjusted to exclude this drug. Although Prinzmetal's angina is relatively uncommon, we suspect that a routine use of cardiac event monitors in subjects with panic disorder might reveal a greater incidence of coronary vasospasm in this patient population.</p>","PeriodicalId":88441,"journal":{"name":"Cardiovascular psychiatry and neurology","volume":"2009 ","pages":"453786"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2009/453786","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28609777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Putative Role of MicroRNA-Regulated Pathways in Comorbid Neurological and Cardiovascular Disorders. microrna调控通路在神经和心血管疾病共病中的作用
Cardiovascular psychiatry and neurology Pub Date : 2009-01-01 Epub Date: 2009-08-24 DOI: 10.1155/2009/849519
Sébastien S Hébert
{"title":"Putative Role of MicroRNA-Regulated Pathways in Comorbid Neurological and Cardiovascular Disorders.","authors":"Sébastien S Hébert","doi":"10.1155/2009/849519","DOIUrl":"10.1155/2009/849519","url":null,"abstract":"<p><p>Background. The conserved noncoding microRNAs (miRNAs) that function to regulate gene expression are essential for the development and function of the brain and heart. Changes in miRNA expression profiles are associated with an increased risk for developing neurodegenerative disorders as well as heart failure. Here, the hypothesis of how miRNA-regulated pathways could contribute to comorbid neurological and cardiovascular disorders will be discussed. Presentation. Changes in miRNA expression occurring in the brain and heart could have an impact on coexisting neurological and cardiovascular characteristics by (1) modulating organ function, (2) accentuating cellular stress, and (3) impinging on neuronal and/or heart cell survival. Testing. Evaluation of miRNA expression profiles in the brain and heart tissues from individuals with comorbid neurodegenerative and cardiovascular disorders will be of great importance and relevance. Implications. Careful experimental design will shed light to the deeper understanding of the molecular mechanisms tying up those different but yet somehow connected diseases.</p>","PeriodicalId":88441,"journal":{"name":"Cardiovascular psychiatry and neurology","volume":"2009 ","pages":"849519"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2009/849519","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28610280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
The GRK2 Overexpression Is a Primary Hallmark of Mitochondrial Lesions during Early Alzheimer Disease. GRK2过表达是早期阿尔茨海默病线粒体病变的主要标志。
Cardiovascular psychiatry and neurology Pub Date : 2009-01-01 Epub Date: 2010-03-03 DOI: 10.1155/2009/327360
Mark E Obrenovich, Hector H Palacios, Eldar Gasimov, Jerzy Leszek, Gjumrakch Aliev
{"title":"The GRK2 Overexpression Is a Primary Hallmark of Mitochondrial Lesions during Early Alzheimer Disease.","authors":"Mark E Obrenovich,&nbsp;Hector H Palacios,&nbsp;Eldar Gasimov,&nbsp;Jerzy Leszek,&nbsp;Gjumrakch Aliev","doi":"10.1155/2009/327360","DOIUrl":"https://doi.org/10.1155/2009/327360","url":null,"abstract":"<p><p>Increasing evidence points to vascular damage as an early contributor to the development of two leading causes of age-associated dementia, namely Alzheimer disease (AD) and AD-like pathology such as stroke. This review focuses on the role of G protein-coupled receptor kinases (GRKs) as they relate to dementia and how the cardio and cerebrovasculature is involved in AD pathogenesis. The exploration of GRKs in AD pathogenesis may help bridge gaps in our understanding of the heart-brain connection in relation to neurovisceral damage and vascular complications of AD. The a priori basis for this inquiry stems from the fact that kinases of this family regulate numerous receptor functions in the brain, myocardium and elsewhere. The aim of this review is to discuss the finding of GRK2 overexpression in the context of early AD pathogenesis. Also, we consider the consequences for this overexpression as a loss of G-protein coupled receptor (GPCR) regulation, as well as suggest a potential role for GPCRs and GRKs in a unifying theory of AD pathogenesis through the cerebrovasculature. Finally, we synthesize this newer information in an attempt to put it into context with GRKs as regulators of cellular function, which makes these proteins potential diagnostic and therapeutic targets for future pharmacological intervention.</p>","PeriodicalId":88441,"journal":{"name":"Cardiovascular psychiatry and neurology","volume":"2009 ","pages":"327360"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2009/327360","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28754352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 36
Possible treatment concepts for the levodopa-related hyperhomocysteinemia. 左旋多巴相关高同型半胱氨酸血症的可能治疗方案。
Cardiovascular psychiatry and neurology Pub Date : 2009-01-01 Epub Date: 2009-09-09 DOI: 10.1155/2009/969752
Thomas Müller
{"title":"Possible treatment concepts for the levodopa-related hyperhomocysteinemia.","authors":"Thomas Müller","doi":"10.1155/2009/969752","DOIUrl":"10.1155/2009/969752","url":null,"abstract":"<p><p>The saga of harmful levodopa (LD) in the treatment of Parkinson's disease (PD) resulted from outcomes of animal-and cell culture studies and the clinical observation of motor complication related to the short half life of LD. Further aspects of LD long term application, the LD associated homocysteine increase and its emerging consequences on progression, and onset of neuropsychiatric symptoms and of vascular disease are only partially considered. Therapeutic approaches for this LD-mediated neurotoxic homocysteine increase are vitamin supplementation or LD application with an inhibitor of catechol-O-methyltransferase (COMT). However, forcing central dopamine metabolism further down the methylation path by central blocking of COMT and MAO-B may reduce oxidative stress and homocysteine levels. But it may also increase N-methylation of tetrahydroisoquinolines to neurotoxic N-methylated tetrahydroisoquinolines. These compounds were observed in cerebrospinal fluid and plasma of long term LD-treated PD patients. Therefore LD application with peripheral COMT inhibition may be safer.</p>","PeriodicalId":88441,"journal":{"name":"Cardiovascular psychiatry and neurology","volume":"2009 ","pages":"969752"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2794520/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28610221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信